Halozyme Therapeutics
HALO
#2115
Rank
S$9.87 B
Marketcap
$80.18
Share price
1.04%
Change (1 day)
43.70%
Change (1 year)

Halozyme Therapeutics (HALO) - Total debt

Total debt on the balance sheet as of December 2024 : S$2.00 Billion

According to Halozyme Therapeutics's latest financial reports the company's total debt is S$2.00 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Halozyme Therapeutics - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2023-12-31S$1.98 B-1.93%
2022-12-31S$2.01 B70.36%
2021-12-31S$1.18 B125.53%
2020-12-31S$0.52 B-3.18%
2019-12-31S$0.54 B214.36%
2018-12-31S$0.17 B-36.21%
2017-12-31S$0.27 B-13.67%
2016-12-31S$0.31 B344.76%
2015-12-31S$70.49 M6.99%
2014-12-31S$65.88 M4.47%
2013-12-31S$63.06 M65.75%
2012-12-31S$38.04 M
2011-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
S$0.32 B-84.04%๐Ÿ‡บ๐Ÿ‡ธ USA
S$44.84 B 2,134.31%๐Ÿ‡บ๐Ÿ‡ธ USA
S$17.58 B 776.21%๐Ÿ‡บ๐Ÿ‡ธ USA
S$88.80 B 4,324.03%๐Ÿ‡บ๐Ÿ‡ธ USA
S$24.83 B 1,137.44%๐Ÿ‡ซ๐Ÿ‡ท France
S$48.83 B 2,332.86%๐Ÿ‡บ๐Ÿ‡ธ USA